thienopyridine: Clinical Trials

3 trials of thienopyridine, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed. 3 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 33Completed 3

Follow thienopyridine: new trials by email Literature Review of thienopyridine trials Research Report on thienopyridine

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
PLATINUM Trial to Assess the PROMUS Element Stent System for Treatment of De Novo Coronary Artery Lesions-Pharmacokinetics (PLATINUM PK)
PROMUS Element Everolimus-Eluting Coronary Stent System, Aspirin, Thienopyridine - Coronary Artery Disease
Phase 3CompletedBoston Scientific Corporation222009-10-012019-03-26
The PLATINUM Clinical Trial to Assess the PROMUS Element Stent System for Treatment of Long De Novo Coronary Artery Lesions (PLATINUM LL)
PROMUS Element Coronary Stent System, Aspirin, Thienopyridine - Coronary Artery Disease
Phase 3CompletedBoston Scientific Corporation1022009-02-012019-03-26
The PLATINUM Clinical Trial to Assess the PROMUS Element Stent System for Treatment of De Novo Coronary Artery Lesions
PROMUS Coronary Stent System, PROMUS Element Coronary Stent System, Aspirin - Coronary Artery Disease
Phase 3CompletedBoston Scientific Corporation15302009-01-012019-03-27

Conditions studied

Coronary Artery Disease (3)

Sponsors

Boston Scientific Corporation (3)

Countries

Japan (3)  ·  United States (3)  ·  Australia (2)  ·  Belgium (2)  ·  France (2)  ·  Latvia (2)  ·  New Zealand (2)  ·  Austria (1)  ·  Denmark (1)  ·  Finland (1)  ·  Germany (1)  ·  Malaysia (1)  ·  Netherlands (1)  ·  Poland (1)  ·  Portugal (1)

Top investigators

Peter M. Maurer, MPH (2)  ·  Peter M Maurer, MPH (1)

Results publications

PMID 29217001, PMID 21470815, PMID 24905795